$PYCR
PAYCOR HCM, INC. Stock $pycr

$pycr Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000183943924000009 Filed on February 08, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2022 Q4
Revenue	$187.0M	$159.5M	$132.9M
YoY Change	15.81%	20.08%	28.91%
Cost Of Revenue	$58.74M	$55.13M	$46.18M
YoY Change	19.08%	19.36%	12.42%
Gross Profit	$128.3M	$104.4M	$86.68M
YoY Change	14.38%	20.46%	39.84%
Gross Profit Margin	68.59%	65.45%	65.24%
Selling, General & Admin	$105.8M	$113.9M	$104.4M
YoY Change	-0.72%	9.15%	22.59%
% of Gross Profit	82.44%	109.11%	120.41%
Research & Development	$15.07M	$16.67M	$13.88M
YoY Change	10.32%	20.11%	30.83%
% of Gross Profit	11.75%	15.96%	16.01%
Depreciation & Amortization	$1.467M	$1.486M	$1.196M
YoY Change	24.85%	24.25%	-30.87%
% of Gross Profit	1.14%	1.42%	1.38%
Operating Expenses	$120.8M	$130.6M	$118.2M
YoY Change	0.53%	10.44%	23.5%
Operating Profit	$7.456M	-$26.18M	-$31.57M
YoY Change	-192.84%	-17.09%	-6.5%
Interest Expense	$1.146M	$1.153M	$404.0K
YoY Change	-41.83%	185.4%	260.71%
% of Operating Profit	15.37%
Other Income/Expense, Net	$1.133M	-$1.745M	$66.00K
YoY Change	-43.43%	-2743.94%	-79.88%
Pretax Income	$7.443M	-$29.07M	-$31.91M
YoY Change	-193.06%	-8.88%	-4.89%
Income Tax	$1.250M	-$2.824M	-$4.444M
% Of Pretax Income	16.79%
Net Earnings	$6.193M	-$26.25M	-$27.46M
YoY Change	-184.37%	-4.42%	7.85%
Net Earnings / Revenue	3.31%	-16.45%	-20.67%
Basic Earnings Per Share	$0.03	-$0.15	-$0.16
Diluted Earnings Per Share	$0.03	-$0.15	-$0.16
COMMON SHARES
Basic Shares Outstanding	178.0M shares	177.6M shares	175.9M shares
Diluted Shares Outstanding	178.0M shares	177.6M shares	175.8M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$90.10M	$61.72M	$72.28M
YoY Change	8.74%	-14.61%	-34.94%
Cash & Equivalents	$90.10M	$61.72M	$72.28M
Short-Term Investments
Other Short-Term Assets	$7.772M	$9.307M	$3.956M
YoY Change	119.98%	135.26%	304.91%
Inventory
Prepaid Expenses	$16.99M	$12.86M	$12.99M
Receivables	$43.99M	$44.95M	$31.91M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.644B	$1.517B	$1.350B
YoY Change	13.99%	12.37%	20.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$35.78M	$36.89M	$31.99M
YoY Change	13.93%	15.33%	-17.84%
Goodwill	$766.7M	$767.2M	$770.1M
YoY Change	0.7%	-0.38%	2.63%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.344M	$2.921M	$2.794M
YoY Change	-16.21%	4.55%	-87.22%
Total Long-Term Assets	$1.261B	$1.276B	$1.323B
YoY Change	-3.04%	-3.53%	5.32%
TOTAL ASSETS
Total Short-Term Assets	$1.644B	$1.517B	$1.350B
Total Long-Term Assets	$1.261B	$1.276B	$1.323B
Total Assets	$2.905B	$2.793B	$2.673B
YoY Change	5.92%	4.5%	12.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.01M	$25.51M	$20.28M
YoY Change	-4.68%	25.76%	69.8%
Accrued Expenses	$61.84M	$61.81M	$56.92M
YoY Change	11.49%	8.59%	43.17%
Deferred Revenue	$14.02M	$13.36M	$11.45M
YoY Change	10.16%	16.7%	7.03%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$291.0K
YoY Change
Total Short-Term Liabilities	$1.516B	$1.426B	$1.276B
YoY Change	12.36%	11.75%	27.29%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$70.25M	$70.94M	$83.87M
YoY Change	0.35%	-15.42%	673.47%
Total Long-Term Liabilities	$70.25M	$70.94M	$83.87M
YoY Change	0.35%	-15.42%	673.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.516B	$1.426B	$1.276B
Total Long-Term Liabilities	$70.25M	$70.94M	$83.87M
Total Liabilities	$1.614B	$1.525B	$1.405B
YoY Change	10.72%	8.55%	30.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$530.1M	-$536.3M	-$451.9M
YoY Change	15.44%	18.68%	27.34%
Common Stock	$178.0K	$178.0K	$176.0K
YoY Change	1.14%	1.14%	1.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)			$245.1M
YoY Change			0.0%
Treasury Stock Shares
Shareholders Equity	$1.291B	$1.268B	$1.268B
YoY Change
Total Liabilities & Shareholders Equity	$2.905B	$2.793B	$2.673B
YoY Change	5.92%	4.5%	12.67%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	$6.193M	-$26.25M	-$27.46M
YoY Change	-184.37%	-4.42%	7.85%
Depreciation, Depletion And Amortization	$1.467M	$1.486M	$1.196M
YoY Change	24.85%	24.25%	-30.87%
Cash From Operating Activities	$39.66M	$26.17M	$5.603M
YoY Change	13.7%	367.02%	-478.84%
INVESTING ACTIVITIES
Capital Expenditures	$14.16M	$16.81M	$12.23M
YoY Change	-46.27%	37.47%	-218.84%
Acquisitions
YoY Change
Other Investing Activities	-$189.0K	-$49.62M	-$20.15M
YoY Change	-358.9%	146.33%	4028.07%
Cash From Investing Activities	-$14.35M	-$66.43M	-$32.37M
YoY Change	-45.4%	105.22%	200.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	96.36M	285.1M	247.7M
YoY Change	24.27%	15.12%	-138.77%
NET CHANGE
Cash From Operating Activities	39.66M	26.17M	5.603M
Cash From Investing Activities	-14.35M	-66.43M	-32.37M
Cash From Financing Activities	96.36M	285.1M	247.7M
Net Change In Cash	121.7M	244.9M	220.9M
YoY Change	41.25%	10.84%	-133.93%
FREE CASH FLOW
Cash From Operating Activities	$39.66M	$26.17M	$5.603M
Capital Expenditures	$14.16M	$16.81M	$12.23M
Free Cash Flow	$25.50M	$9.358M	-$6.624M
YoY Change	199.18%	-241.27%	-175.19%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P6M
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1350000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1267996000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1269415000	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	177260396	shares
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-26249000	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	23049000	usd
CY2023Q4	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1411000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	1000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3456000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1268261000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1284731000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-56515000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	37635000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1727000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	4645000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-773000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1267996000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1273684000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-46845000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	35964000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1829000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	4173000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3114000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1268261000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-46845000	usd
	us-gaap	Depreciation Depreciation	2997000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	68312000	usd
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	29876000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	35964000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5937000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2870000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-142000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-4000	usd
	pycr	Gain Loss On Lease Exit Including Accretion Expense GainLossOnLeaseExitIncludingAccretionExpense	29000	usd
	us-gaap	Accretion Expense AccretionExpense	2061000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2816000	usd
	us-gaap	Proceeds From Other Operating Activities ProceedsFromOtherOperatingActivities	44000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17003000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7487000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3207000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-10892000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	151939000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	103453000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2068000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4133000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	28000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	25308000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-80023000	usd
	pycr	Net Change In Client Fund Obligations NetChangeInClientFundObligations	270540000	usd
	pycr	Payments For Capital Expenditure Financing PaymentsForCapitalExpenditureFinancing	3689000	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	536000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1829000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	4172000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	268658000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	188683000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	879046000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	39000	usd
	us-gaap	Interest Paid Net InterestPaidNet	145000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	pycr	Capital Lease Asset Obtained In Exchange For Capital Lease Liabilities CapitalLeaseAssetObtainedInExchangeForCapitalLeaseLiabilities	3393000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	61719000	usd
CY2023Q4	pycr	Funds Held For Clients Cash FundsHeldForClientsCash	1006010000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1067729000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of estimates </span><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Significant items subject to such estimates and assumptions include the evaluation of potential impairment of goodwill and intangible assets and the valuation of stock-based compensation.</span></div>The Company’s results of operations and financial condition can also be affected by economic, political, legislative, regulatory and legal actions, including but not limited to health epidemics and pandemics and their resulting economic impact. Economic conditions, such as recessionary trends, inflation, interest and monetary exchange rates, and government fiscal policies can have a significant effect on the Company’s results of operations and financial condition. While the Company maintains reserves for anticipated liabilities and carries various levels of insurance, the Company could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings.
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9852000	usd
CY2023Q4	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	8440000	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	23049000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	147232000	usd
CY2023Q4	pycr	Implementation Fee Recognition Period ImplementationFeeRecognitionPeriod	P24M
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	18712000	usd
CY2023Q4	pycr	Contract With Customer Liability Acquired Deferred Revenue ContractWithCustomerLiabilityAcquiredDeferredRevenue	0	usd
CY2023Q4	pycr	Contract With Customer Liability Deferral Of Revenue ContractWithCustomerLiabilityDeferralOfRevenue	5165000	usd
CY2023Q4	pycr	Contract With Customer Liability Revenue Recognized Including Current Period Revenue ContractWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriodRevenue	4950000	usd
CY2023Q4	pycr	Contract With Customer Liability Foreign Exchange Gain Loss ContractWithCustomerLiabilityForeignExchangeGainLoss	25000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	18952000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	7650000	usd
CY2023Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	229825000	usd
CY2023Q4	pycr	Capitalized Contract Cost Additions CapitalizedContractCostAdditions	26818000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	15510000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	241133000	usd
CY2022Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	175216000	usd
CY2022Q4	pycr	Capitalized Contract Cost Additions CapitalizedContractCostAdditions	25755000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	11066000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	189905000	usd
CY2023Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	217105000	usd
	pycr	Capitalized Contract Cost Additions CapitalizedContractCostAdditions	53904000	usd
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	29876000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	241133000	usd
CY2022Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	163474000	usd
	pycr	Capitalized Contract Cost Additions CapitalizedContractCostAdditions	47525000	usd
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	21094000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	189905000	usd
CY2023Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	0	usd
CY2022Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	1174000	usd
CY2023Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	0	usd
CY2022Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	1174000	usd
CY2023Q4	pycr	Funds Held For Clients Amortized Cost FundsHeldForClientsAmortizedCost	1325175000	usd
CY2023Q4	pycr	Funds Held For Clients Gross Unrealized Gains FundsHeldForClientsGrossUnrealizedGains	26000	usd
CY2023Q4	pycr	Funds Held For Clients Gross Unrealized Losses FundsHeldForClientsGrossUnrealizedLosses	38000	usd
CY2023Q4	us-gaap	Funds Held For Clients FundsHeldForClients	1325163000	usd
CY2023Q2	pycr	Funds Held For Clients Amortized Cost FundsHeldForClientsAmortizedCost	1053309000	usd
CY2023Q2	pycr	Funds Held For Clients Gross Unrealized Gains FundsHeldForClientsGrossUnrealizedGains	93000	usd
CY2023Q2	pycr	Funds Held For Clients Gross Unrealized Losses FundsHeldForClientsGrossUnrealizedLosses	4246000	usd
CY2023Q2	us-gaap	Funds Held For Clients FundsHeldForClients	1049156000	usd
CY2023Q4	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	79801000	usd
CY2023Q4	pycr	Funds Held For Clients Maturities Year One FundsHeldForClientsMaturitiesYearOne	1058834000	usd
CY2023Q4	pycr	Funds Held For Clients Maturities Year Two FundsHeldForClientsMaturitiesYearTwo	80096000	usd
CY2023Q4	pycr	Funds Held For Clients Maturities Year Three FundsHeldForClientsMaturitiesYearThree	112546000	usd
CY2023Q4	pycr	Funds Held For Clients Maturities Year Four FundsHeldForClientsMaturitiesYearFour	50062000	usd
CY2023Q4	pycr	Funds Held For Clients Maturities Year Five FundsHeldForClientsMaturitiesYearFive	21397000	usd
CY2023Q4	pycr	Funds Held For Clients Maturities After Year Five FundsHeldForClientsMaturitiesAfterYearFive	2228000	usd
CY2023Q4	pycr	Funds Held For Clients Maturities FundsHeldForClientsMaturities	1325163000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	60607000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23714000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36893000	usd
CY2023Q4	us-gaap	Depreciation Depreciation	1486000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	151015000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	89363000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	61652000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	9166000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	767738000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	6000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	767193000	usd
CY2022Q3	pycr	Partnership Agreement PartnershipAgreement	P16Y
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	790958000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	576877000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	214081000	usd
CY2023Q4	pycr	Amortization Of Intangible Assets Excluding Capitalized Computer Software AmortizationOfIntangibleAssetsExcludingCapitalizedComputerSoftware	24963000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	46797000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	44591000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	17623000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	12332000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	12244000	usd
CY2023Q4	pycr	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	80494000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	214081000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2023Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	0	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	177634296	shares
CY2023Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	5000000	shares
CY2023Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26249000	usd
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	177567397	shares
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	177567397	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	175830554	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	177260396	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	177260396	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	175671565	shares
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
pycr-20231231_cal.xml	Edgar Link	unprocessable
pycr-20231231_def.xml	Edgar Link	unprocessable
pycr-20231231_lab.xml	Edgar Link	unprocessable
pycr-20231231_pre.xml	Edgar Link	unprocessable
0001839439-24-000009-index-headers.html	Edgar Link	pending
0001839439-24-000009-index.html	Edgar Link	pending
0001839439-24-000009.txt	Edgar Link	pending
0001839439-24-000009-xbrl.zip	Edgar Link	pending
a2024pycrq2-ex311xceosoxce.htm	Edgar Link	pending
a2024pycrq2-ex312xcfosoxce.htm	Edgar Link	pending
a2024pycrq2-ex321xceosecti.htm	Edgar Link	pending
a2024pycrq2-ex322xcfosecti.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pycr-20231231.htm	Edgar Link	pending
pycr-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
pycr-20231231_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PYCR
PAYCOR HCM, INC. Stock $pycr

2024 Q1 Form 10-Q Financial Statement

#000183943924000009 Filed on February 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PYCR PAYCOR HCM, INC. Stock $pycr

2024 Q1 Form 10-Q Financial Statement

#000183943924000009 Filed on February 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PYCR
PAYCOR HCM, INC. Stock $pycr